Altimmune, Inc. (ALT) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts ALT Hot Sheet
Join SI Premium – FREE
Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.18), $0.06 better than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Leerink Starts Altimmune (ALT) at Outperform
- A.O. Smith executive chairman to retire, CEO to assume chairman role
- Lockheed Martin wins $83 million Army missile contract
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
